Treatment satisfaction, symptom control and quality of life (QoL) with Lanreotide Autogel (LAN) in NET patients with carcinoid syndrome (CS): results from the SYMNET study.
Ruszniewski, P Caplin, M Valle, Juan W Lombard-Bohas, C Poston, G Perros, P Holubec, L Delle, F Smith, D Niccoli, P
Ruszniewski, P
Caplin, M
Valle, Juan W
Lombard-Bohas, C
Poston, G
Perros, P
Holubec, L
Delle, F
Smith, D
Niccoli, P
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Treatment satisfaction, symptom control and quality of life (QoL) with Lanreotide Autogel (LAN) in NET patients with carcinoid syndrome (CS): results from the SYMNET study. 2015, 102 (42036):126-126 Neuroendocrin